BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mota STS, Vecchi L, Zóia MAP, Oliveira FM, Alves DA, Dornelas BC, Bezerra SM, Andrade VP, Maia YCP, Neves AF, Goulart LR, Araújo TG. New Insights into the Role of Polybromo-1 in Prostate Cancer. Int J Mol Sci 2019;20:E2852. [PMID: 31212728 DOI: 10.3390/ijms20122852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ertl IE, Brettner R, Kronabitter H, Mohr T, Derdak S, Jeitler M, Bilban M, Garstka N, Shariat SF. The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer. Cells 2022;12. [PMID: 36611918 DOI: 10.3390/cells12010124] [Reference Citation Analysis]
2 Miao XY, Wu H, Ye BC, Yi QW, Lin FN, Wang YL, Ren CL, Jiang YF, Li A. Non‑small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB. Sci Rep 2022;12:20734. [PMID: 36456601 DOI: 10.1038/s41598-022-25050-3] [Reference Citation Analysis]
3 Silva FCD, Araújo BJD, Cordeiro CS, Arruda VM, Faria BQ, Guerra JFDC, Araújo TGD, Fürstenau CR. Endothelial dysfunction due to the inhibition of the synthesis of nitric oxide: Proposal and characterization of an in vitro cellular model. Front Physiol 2022;13. [DOI: 10.3389/fphys.2022.978378] [Reference Citation Analysis]
4 Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC. Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening. J Med Chem 2022. [PMID: 36227159 DOI: 10.1021/acs.jmedchem.2c00864] [Reference Citation Analysis]
5 De Silva SM, Sood S, Dhiman A, Mercedes KF, Henen MA, Vögeli B, Dykhuizen EC, Musselman CA. PBRM1 BD2 and BD4 associate with RNA to facilitate chromatin association.. [DOI: 10.1101/2022.02.07.479474] [Reference Citation Analysis]
6 Liu T, Xia Q, Zhang H, Wang Z, Yang W, Gu X, Hou T, Chen Y, Pei X, Zhu G, He D, Li L, Xu S. CCL5-dependent mast cell infiltration into the tumor microenvironment in clear cell renal cell carcinoma patients. Aging (Albany NY) 2020;12:21809-36. [PMID: 33177244 DOI: 10.18632/aging.103999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
7 Mota STS, Vecchi L, Alves DA, Cordeiro AO, Guimarães GS, Campos-Fernández E, Maia YCP, Dornelas BC, Bezerra SM, de Andrade VP, Goulart LR, Araújo TG. Annexin A1 promotes the nuclear localization of the epidermal growth factor receptor in castration-resistant prostate cancer. Int J Biochem Cell Biol 2020;127:105838. [PMID: 32858191 DOI: 10.1016/j.biocel.2020.105838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Zhou H, Liu J, Zhang Y, Huang Y, Shen J, Yang Y, Fang W, Zhang L. PBRM1 mutation and preliminary response to immune checkpoint blockade treatment in non-small cell lung cancer. NPJ Precis Oncol 2020;4:6. [PMID: 32195359 DOI: 10.1038/s41698-020-0112-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]